IP Verse

Ethypharm patent opposition analysis

Get complete Patent Opposition Report for Ethypharm

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Ethypharm

Explore patent oppositions filed by Ethypharm against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3578173	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Jul 26, 2023
EP3345602	Rapamycin Derivative For Treating Advanced Solid Tumours	NOVARTIS	Jan 6, 2023
EP3391890	Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin	MERCK SHARP & DOHME	May 25, 2022
EP3342411	Rapamycin Derivative For Treating Pancreas Cancer	NOVARTIS	Feb 14, 2020
EP2962686	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Jan 9, 2020
EP3351246	Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis	NOVARTIS	Jul 3, 2019
EP3143995	A Rapamycin Derivative For Treating Lung Cancer	NOVARTIS	Jun 12, 2019
EP2762140	Treatment Of Solid Brain Tumours With A Rapamycin Derivative	NOVARTIS	Dec 22, 2017
EP2425821	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	Nov 7, 2017
EP2425824	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	Nov 7, 2017

Latest patents of Ethypharm opposed by its competitors

Explore Ethypharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3115041	Oct 25, 2023	Crush-Resistant Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion	2

Top competitors of Ethypharm

MUNDIPHARMA

NOVARTIS

EURO CELTIQUE